Discover
ARQT
Arcutis Biotherapeutics, Inc.
25.84
2 x 18.65
2 x 33.08
bid
ask
-
0.38
1.45%
2 @ 06:59 AM
25.91 +0.07 (0.27%)
| Ytd | -11.02% | |
| 1y | 87.93% |
25.83
day range
26.46
13.06
52 week range
31.77
| Open | 26.40 | Prev Close | 26.22 | Low | 25.83 | High | 26.46 | Mkt Cap | 3.23B |
| Vol | 932.22K | Avg Vol | 1.72M | EPS | -0.02 | P/E | N/A | Forward P/E | 22.36 |
| Beta | 1.52 | Short Ratio | 9.07 | Inst. Own | 110.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 23.10 | 200-d Avg | 24.38 | 1yr Est | 34.63 |
| Income Statement | |||
| Total Revenue | 105.40M | ||
| Revenues (USD) | 105.40M | ||
| Cost of Revenue | 9.78M | ||
| Gross Profit | 95.61M | ||
| Operating Expenses | 104.70M | ||
| Research and Development Expense | 30.63M | ||
| Selling, General and Administrative Expense | 74.08M | ||
| Operating Income | -9.09M | ||
| Interest Expense | 4.37M | ||
| Income Tax Expense | 93.00K | ||
| Net Income | -11.29M | ||
| Net Income Common Stock | -11.29M | ||
| Net Income Common Stock (USD) | -11.29M | ||
| Consolidated Income | -11.29M | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -6.83M | ||
| Earning Before Interest & Taxes (USD) | -6.83M | ||
| Weighted Average Shares | 129.37M | ||
| Weighted Average Shares Diluted | 129.37M | ||
| Balance Sheet | |||
| Cash and Equivalents | 35.07M | ||
| Cash and Equivalents (USD) | 35.07M | ||
| Investments | 189.24M | ||
| Investments Current | 189.24M | ||
| Trade and Non-Trade Receivables | 144.38M | ||
| Current Assets | 438.06M | ||
| Property, Plant & Equipment Net | 5.40M | ||
| Total Assets | 460.00M | ||
| Debt Current | 7.95M | ||
| Total Debt | 114.67M | ||
| Current Liabilities | 163.20M | ||
| Debt Non-Current | 106.72M | ||
| Total Liabilities | 270.36M | ||
| Accumulated Retained Earnings (Deficit) | -1.15B | ||
| Accumulated Other Comprehensive Income | -514.00K | ||
| Shareholders Equity | 189.65M | ||
| Shareholders Equity (USD) | 189.65M | ||
| Assets Non-Current | 21.95M | ||
| Total Debt (USD) | 114.67M | ||
| Goodwill and Intangible Assets | 14.25M | ||
| Inventory | 37.39M | ||
| Liabilities Non-Current | 107.15M | ||
| Trade and Non-Trade Payables | 18.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 562.00K | ||
| Net Cash Flow from Financing | 1.07M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.14M | ||
| Issuance (Purchase) of Equity Shares | 1.07M | ||
| Net Cash Flow from Investing | -11.33M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -11.33M | ||
| Net Cash Flow from Operations | 2.24M | ||
| Effect of Exchange Rate Changes on Cash | -119.00K | ||
| Share Based Compensation | 10.69M | ||